Content:
Overview
Content on this page:
Overview
Content on this page:
Overview
Overview
Patients with diabetes are prone to have invasion and multiplication of microorganisms in the soft tissue or bone (anywhere below the malleoli) called diabetic foot infection that leads to host inflammatory response that usually results to tissue destruction.
It is not common in patients with diabetic foot infection to have systemic symptoms (eg fever and chills), marked leukocytosis or major metabolic disturbance but its presence will indicate a more severe, potentially limb or even life-threatening infection.
Clinical findings of local and systemic signs and symptoms of inflammation or purulence is essential in the diagnosis of diabetic foot infection.
Management of diabetic foot ulcer in patients with diabetes needs an interdisciplinary approach to address glycemic control, infection, offloading of high-pressure areas, lower extremity vascular status and local wound care.
For further information regarding the management of Diabetic Foot Infection, please refer to Disease Algorithm for the Treatment Guideline.
It is not common in patients with diabetic foot infection to have systemic symptoms (eg fever and chills), marked leukocytosis or major metabolic disturbance but its presence will indicate a more severe, potentially limb or even life-threatening infection.
Clinical findings of local and systemic signs and symptoms of inflammation or purulence is essential in the diagnosis of diabetic foot infection.
Management of diabetic foot ulcer in patients with diabetes needs an interdisciplinary approach to address glycemic control, infection, offloading of high-pressure areas, lower extremity vascular status and local wound care.
For further information regarding the management of Diabetic Foot Infection, please refer to Disease Algorithm for the Treatment Guideline.
